IRadimed Stock
IRadimed Corporation
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Roger E. Susi
- Employees
- 166
- Market cap
- $1.1 B
- IPO
- 16/07/2014
IRadimed Corporation is a healthcare company operating in the medical devices industry, headquartered in Orlando, USA. Founded in 1992, the company specializes in the engineering, production, and distribution of medical devices specifically designed for compatibility with magnetic resonance imaging (MRI) environments.…
Company description based on the data provider's company data, AI-assisted, created on 17/10/2026. Not investment advice.
IRadimed stock: price history
1D
-1.2%
1W
+0.9%
1M
+6.9%
6M
-5.8%
YTD
-9.3%
1Y
+16.1%
2Y
+71.2%
5Y
+140.7%
10Y
+835.1%
Next earnings date
Next earnings date
02/11/2026 (in 16 days)
Volatility around earnings
~38% stronger price swings than usual
Ask the agents about IRadimed
Analyst assessment of IRadimed
PRICE TARGET LOW
US$60.00
CONSENSUS
US$100.00
MEDIAN
US$120.00
PRICE TARGET HIGH
US$120.00
0
STRONG BUY
2
BUY
0
HOLD
0
SELL
0
STRONG SELL
2
TOTAL · Buy
As of: 14/02/2025
IRadimed stock metrics
P/E
48.5
P/B
11.09
EV/EBITDA
34.64
RETURN ON EQUITY
5.1%
NET MARGIN
25.5%
DEBT/EQUITY
0
DIVIDEND YIELD
1.4%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
65.1%
FLOAT SHARES
8,330,213
AVG. DAILY VOLUME (30D)
131,296
Insider transactions (SEC)
KIANI JOE E
ALLEN MONTY K
ALLEN MONTY K
GLENN JOHN
GLENN JOHN
Institutional holders
Dividends
Comparable stocks
Frequently asked questions about IRadimed stock
What does IRadimed do?
IRadimed Corporation is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Roger E. Susi, the company employs around 166 people.
The IPO was on 16/07/2014; the stock trades on NASDAQ under the ticker IRMD.
What do analysts say about IRadimed stock?
2 analysts rate the stock, the consensus is Buy (as of 14/02/2025).
The average price target is US$100.00, ranging from US$60.00 to US$120.00, with a median of US$120.00.
This is an external assessment, not a statement by Market Jury.
When does IRadimed report next?
The next earnings date is 02/11/2026.
Around past earnings, price swings were roughly 38% stronger than usual.
Does IRadimed pay a dividend?
Yes. The last dividend was US$0.20 per share, ex-date 14/08/2026, paid on 28/08/2026.
The dividend yield is 1.4% (as of 30/06/2026).
Which stocks are comparable to IRadimed?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get IRadimed stock analyzed?
Clicking "Analyze stock" lets five strategies assess IRadimed against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.